article thumbnail

What Could Rescheduling Mean for Medical Cannabis Patients?

Canna Care Docs

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. In this blog, we’ll break down what the big news means and what could happen next. In this blog, we’ll break down what the big news means and what could happen next.

Patients 111
article thumbnail

One Signature Could Remove Marijuana From Schedule I Tomorrow

Canna Law Blog

Yes, the DEA would need to do some light follow-up rulemaking—but that’s been done before , and the Office of Legal Counsel has already signed off on it. In fact, even if marijuana gets rescheduled via the full DEA/HHS process and lands in Schedule III, a future AG could use § 811(d)(1) to shove it right back into Schedule I.

Marijuana 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

America’s Missed Opportunity in the Global Marijuana Market

Canna Law Blog

Of note, in this blog post I use the word cannabis when referring to the entire plant; it is also the word used in the 1961 Single Convention. As I discussed in The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers , U.S. Optimism surrounding the European cannabis market was everywhere. How the U.S.

DEA 113
article thumbnail

Locked Out: SBA’s New Lending Policy Targets Hemp and Marijuana-Adjacent Businesses

Canna Law Blog

Further, other federal agencies may see that neither DEA nor FDA need to enforce federal law to shut down the Consumable Hemp Product industry. Unlike well-funded operators with access to private capital, they depend on SBA programs to survive and grow. With this new policy, compliance confusion becomes a death sentence.

Policy 56
article thumbnail

The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers

Canna Law Blog

But there’s a group of players who’ve been surprisingly quiet, despite potentially having the most to gain: DEA-registered bulk marijuana manufacturers. However, under current US law, DEA Registrants are missing out on a massive opportunity. This booming global market is one that DEA Registrants are unable to access.

DEA 69
article thumbnail

Is There a Method to the Mayhem? The Stock Market and a Potential Cannabis Collapse

Canna Law Blog

While the FDA has recommended moving cannabis to Schedule III , and the DEA has been reviewing that recommendation for months, the process is currently stalled. But if the DEA fails to act, and soon, leaving 280E in place, a wave of insolvencies could follow. Disaster for current operators, but an opportunity for savvy investors.

DEA 90
article thumbnail

Rod Kight and Shane Pennington Discuss DEA Lawsuit (Video)

Cannabis Law Report

Rod Kight and Shane Pennington discuss the DEA lawsuit about hemp extracts. As many readers of this blog know, the… Read More.

DEA 81